Similarly, models of PD and AD show that overexpression of PRKN (by means of AAV, lentivirus, germline editing, or introduction of membrane permeable PRKN) reduces cellular pathology and protects against disease progression [518–522]. Here, PRKN is linked to Parkinson disease.